IRIS
GAETA, Giovanni Battista
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.174
NA - Nord America 6.295
AS - Asia 4.865
SA - Sud America 1.041
AF - Africa 74
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 7
Totale 26.473
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 8.772
US - Stati Uniti d'America 6.213
SG - Singapore 1.799
IE - Irlanda 1.786
CN - Cina 1.189
HK - Hong Kong 1.010
UA - Ucraina 972
BR - Brasile 895
GB - Regno Unito 781
DE - Germania 530
IT - Italia 329
SE - Svezia 292
FI - Finlandia 248
VN - Vietnam 233
GR - Grecia 175
TR - Turchia 147
IN - India 140
FR - Francia 130
KR - Corea 98
AR - Argentina 63
JP - Giappone 55
BD - Bangladesh 39
BE - Belgio 34
CZ - Repubblica Ceca 30
CA - Canada 29
ID - Indonesia 28
IQ - Iraq 26
MX - Messico 26
AT - Austria 22
IR - Iran 21
EC - Ecuador 19
PL - Polonia 19
PY - Paraguay 17
NL - Olanda 16
EU - Europa 15
ZA - Sudafrica 15
VE - Venezuela 14
MA - Marocco 13
PK - Pakistan 13
EG - Egitto 12
CO - Colombia 9
DO - Repubblica Dominicana 8
TH - Thailandia 8
TW - Taiwan 8
PE - Perù 7
UY - Uruguay 7
CH - Svizzera 6
DZ - Algeria 6
ET - Etiopia 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
AZ - Azerbaigian 5
BO - Bolivia 5
CL - Cile 5
PH - Filippine 5
RO - Romania 5
TT - Trinidad e Tobago 5
JM - Giamaica 4
JO - Giordania 4
TN - Tunisia 4
CR - Costa Rica 3
ES - Italia 3
GH - Ghana 3
LT - Lituania 3
MD - Moldavia 3
NI - Nicaragua 3
SA - Arabia Saudita 3
AL - Albania 2
AP - ???statistics.table.value.countryCode.AP??? 2
BF - Burkina Faso 2
CI - Costa d'Avorio 2
CY - Cipro 2
EE - Estonia 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
Totale 26.462
Salva come PNG Salva come JPEG
Città #
Moscow 3.082
Dublin 1.780
Jacksonville 1.402
Hong Kong 1.005
Chandler 893
Santa Clara 681
Singapore 587
Dallas 307
Princeton 271
Medford 236
Beijing 168
Boardman 157
Roxbury 140
San Mateo 130
Wilmington 123
Ashburn 122
Ann Arbor 108
Hefei 105
Bengaluru 96
Seoul 96
The Dalles 86
Ho Chi Minh City 83
Woodbridge 83
Bremen 77
Munich 77
Cambridge 72
New York 68
Nanjing 61
São Paulo 60
Des Moines 52
Düsseldorf 47
Hanoi 46
Los Angeles 40
Mountain View 40
Jinan 36
Brussels 34
Caserta 29
Brno 27
Nanchang 27
Rio de Janeiro 26
Venice 26
Napoli 25
Zhengzhou 25
Belo Horizonte 22
Guangzhou 22
Rome 22
Shenyang 22
Norwalk 21
Shanghai 21
Changsha 18
Naples 18
Nuremberg 18
Tianjin 18
Turku 18
Campinas 17
Curitiba 17
Kunming 17
Brasília 16
Helsinki 16
Porto Alegre 16
Haiphong 14
Hangzhou 14
Milan 13
Ningbo 12
Recife 11
Redwood City 11
Santo André 11
Dhaka 10
Haikou 10
Hebei 10
Ottawa 10
Auburn Hills 9
Baghdad 9
Guayaquil 9
Kraków 9
Padova 9
Shenzhen 9
Asunción 8
Da Nang 8
Houston 8
Istanbul 8
Lanzhou 8
Manaus 8
Ninh Bình 8
Taizhou 8
Clifton 7
Osasco 7
Sorocaba 7
São Bernardo do Campo 7
Vienna 7
Warsaw 7
Xi'an 7
Atlanta 6
Aversa 6
Belford Roxo 6
Duque de Caxias 6
Fortaleza 6
Frankfurt am Main 6
Goiânia 6
Groningen 6
Totale 13.296
Salva come PNG Salva come JPEG
Nome #
1) Analisi delle discontinuità di distribuzione e dei tempi di accumulo di radiocolloide in epatopatici cronici: risultati preliminari 413
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients 315
ANTI TNF ALFA IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE E SPONDILOARTRITI HBV CARRIERS OCCULTI:STUDIO RETROSPETTIVO SULLA SICUREZZA 289
Detection of in vivo hepatitis B virus surface antigen mutations-A comparison of four routine screening assays 240
ANTI-TNFα TREATMENT IS ASSOCIATED WITH INCREASED LIVER STIFFNESS IN HBV OCCULT CARRIER PATIENTS 171
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life 161
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 160
3. HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years. 152
Active recruitment strategy in disadvantaged immigrant populations improves the identification of human immunodeficiency but not of hepatitis B or C virus infections 151
Ittero in corso di infezione delle vie urinarie. Presentazione di un caso clinico ed aspetti patogenetici 150
AISF position paper on HCV in immunocompromised patients 149
Patologie virali tropicali (Flavivirus, Filovirus, Arenavirus, Bunyavirus, Togavirus: Chikungunya, 146
AISF position paper on liver disease and pregnancy 142
Bacterial pneumonia in patients with liver cirrhosis, with or without HIV co-infection: a possible definition of antibiotic prophylaxis associated pneumonia (APAP) 141
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania 139
[Elevata prevalenza ma bassa incidenza della infezione da HGV in pazienti con epatite cronica C] 138
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 137
Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance 137
Declining prevalence and increasing awareness of HCV infection in Italy: A population-based survey in five metropolitan areas 135
[Prevalence and risk factors for bacteriuria in patients with cirrhosis] 133
Recommendations for the management of acute hepatitis B: position paper of the italian Society for the study of infectious and tropical diseases 131
Endotoxin protects against chlorpromazine-induced cholestasis in the isolated perfused rat liver 131
Adefovir dipivoxil-associated thrombocytopenia in a patient with chronic hepatitis B 129
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 129
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 129
A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy 128
Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues. 127
Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy. 127
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 126
Absence of mutations in the YMDD motif/B region of the hepatitis B polymerase in famciclovir therapy failure 125
Clinical and histological aspects of chronic HCV infection and cirrhosis 125
[Spontaneous bacterial peritonitis in patients with liver cirrhosis. Differential aspects with portal thrombosis] 125
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 125
Effect of prednisone priming followed by alpha-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial 124
Changing indications for liver transplant: slow decline of hepatitis viruses in Italy 124
Virological patterns of HCV patients with failure to interferon-free regimens. 123
Liver's functional alterations produced from erythromycin estolate in the isolated and perfused rat liver 122
Prolonged treatment of children with chronic hepatitis B with recombinant alpha 2a-interferon: a controlled, randomized study 121
Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients. 121
AASLD Practice Guidelines on chronic hepatitis B and HBV infection in Italy 120
Fattori di rischio per l'infezione tifoidea nell'area geografica del golfo di Napoli 120
Influenza vaccination in patients with cirrhosis and in liver transplant recipients 119
Baseline HBV-DNA level is an important predictor of response to interferon in children with chronic hepatitis B 119
Different changes in mitochondrial apoptotic pathway in lymphocytes and granulocytes in cirrhotic patients with sepsis. 119
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 118
[Cutaneous myiasis from Cordylobia anthropophaga in a traveller returning from Senegal: a case study] 118
Influence of tauroursodeoxycholic and taurodeoxycholic acids on hepatic metabolism and biliary secretion of phosphatidylcholine in the isolated rat liver 116
[Visceral leishmaniasis: its epidemiology, clinical picture and therapy] 116
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 116
Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma. A Cancer of the Liver Italian Program (CLIP 08)retrospective case-control study 115
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP) 115
Prevention of the toxicity of erythromycin estolate in the perfused rat liver by endotoxin 115
Effect of endotoxin tolerance on drug hepatotoxicity: amelioration of taurolithocholate cholestasis in the perfused rat liver 115
Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure 115
Archi-Prevaleat Project. A National Register of Color-Doppler Ultrasonography of the Epi-Aortic Vessels in Patients Living with HIV. 115
Functional changes induced by taurolithocolic acid in the isolated perfused rat liver 114
Effects of bacterial lipopolysaccharide (LPS) on chlorpromazine (CPZ) induced cholestasis in the isolated perfused rat liver 114
Hepatitis delta infection in Italian patients: towards the end of the story? 114
Liver toxicity during copper chronic intoxication in rats 113
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy. 113
[Cryptosporidium infection in immunocompetent and immunocompromised host] 112
A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3 112
Reactivation of hepatitis B virus in cancer patients treated with chemotherapy for solid tumors. Is the prophylaxis really required? 112
Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir 112
Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial 111
Bacterial endotoxin effect on liver plasma membranes (LPM): membrane-bound enzymes as probes of the site of interaction 111
Fever of unknown origin: a systematic review of the literature for 1995-2004 110
Bacterial endotoxin treatment ameliorates erythromycin estolate-induced cholestasis in the isolated perfused rat liver 110
Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta 109
Amphotericin B-induced depression in the phagocytic function of the isolated rat liver and its prevention by nifedipine 109
Effect of pretreatment with bacterial endotoxin on erythromycin estolate-induced cholestasis 109
Chronic endotoxin pretreatment protects from the chlorpromazine induced cholestasis 109
Effetto della eritromicina sulle funzioni escretorie del fegato di ratto isolato 109
Discriminating value of serum bile acids in asymptomatic HBsAg carriers 109
Severe polymyositis due to Toxoplasma gondii in an adult immunocompetent patient: a case report and review of the literature. 109
Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort 109
Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER cohort study (PLoS ONE (2017) 12: 2 (e0172159) DOI: 10.1371/journal.pone.0172159) 109
[Visceral leishmaniasis in Italy. Its epidemiology, clinical picture and therapy] 108
Efficacy of amphotericin B colloidal dispersion in the treatment of Mediterranean visceral leishmaniasis in immunocompetent adult patients 107
Pretreatment of isolated rat hepatocytes with endotoxin decreases erythromicin estolate - induced aspartate transaminase release 107
Combination of Tenofovir Disoproxil Fumarate and Peginterferon alfa-2a Increases Loss of Hepatitis B Surface Antigen in Patients with Chronic Hepatitis B 107
Increased liver stiffness in idiopathic pulmonary fibrosis: a pilot study 107
Doctors in the kitchen. Experiments with cooking bivalve mollusks 106
Endotoxin reduces erythromycine estolate-induced releas of aspartate transaminase from isolated rat liver cells 106
Cholestasis induced by estradiol-17 beta-D-glucuronide: mechanisms and prevention by sodium taurocholate 106
Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study 105
Cholestatic effect of amphotericin B on the isolated perfused rat liver. Preliminary study 105
The role of surgery in transmitting "post-transfusion" hepatitis 105
Potentation of ethanol-induced narcosis in mice by pretreatment with bacterial lipopolysaccharide 105
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis 104
Hepatic excretory function in the endotoxin tolerant rat 104
The homeostasis model assessment of insulin resistance score is not predictive of sustained virologic response in chronic hepatiti s C patients 103
The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients 103
Prospective Validation of the CLIP Score: A New Prognostic System for Patients With Cirrhosis and Hepatocellular Carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators 103
Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy 102
Epidemiology of viral hepatitis in Italy 102
Interference of endotoxin pretreatment on the taurolithocholate induced cholestasis 102
Effect of chronic copper administration on excretory function of rat liver 102
Endotoxin treatment may modulate the expression of hepatotoxicity of membrane-active agents. 100
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 100
Totale 12.700
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.259
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.073 0 0 0 0 0 22 272 220 13 264 222 60
2021/20221.690 148 11 17 62 590 14 30 65 70 97 132 454
2022/20233.346 293 45 38 302 311 286 6 216 1.694 26 56 73
2023/20241.143 113 34 51 110 438 75 10 35 4 25 57 191
2024/20253.550 58 53 34 102 502 309 582 308 526 622 263 191
2025/202612.057 407 516 929 762 1.133 8.310 0 0 0 0 0 0
Totale 26.761